Kim JH - Search Results

1

Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Huang JH, Zhang SN, Choi KJ, Choi IK, Kim JH, Lee MG, Lee M, Kim H, Yun CO. Huang JH, et al. Among authors: kim h, kim jh. Mol Ther. 2010 Feb;18(2):264-74. doi: 10.1038/mt.2009.205. Epub 2009 Sep 8. Mol Ther. 2010. PMID: 19738604 Free PMC article.

2

ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis.

Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH. Yun CO, et al. Among authors: kim e, kim h, kim jh. Cancer Gene Ther. 2005 Jan;12(1):61-71. doi: 10.1038/sj.cgt.7700769. Cancer Gene Ther. 2005. PMID: 15375379

3

Coxsackie and adenovirus receptor binding ablation reduces adenovirus liver tropism and toxicity.

Yun CO, Yoon AR, Yoo JY, Kim H, Kim M, Ha T, Kim GE, Kim H, Kim JH. Yun CO, et al. Among authors: kim h, kim m, kim ge, kim jh. Hum Gene Ther. 2005 Feb;16(2):248-61. doi: 10.1089/hum.2005.16.248. Hum Gene Ther. 2005. PMID: 15761264

4

Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.

Yoon AR, Kim JH, Lee YS, Kim H, Yoo JY, Sohn JH, Park BW, Yun CO. Yoon AR, et al. Among authors: kim h, kim jh. Hum Gene Ther. 2006 Apr;17(4):379-90. doi: 10.1089/hum.2006.17.379. Hum Gene Ther. 2006. PMID: 16610926

5

Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.

Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO. Lee YS, et al. Among authors: kim h, kim jh. Clin Cancer Res. 2006 Oct 1;12(19):5859-68. doi: 10.1158/1078-0432.CCR-06-0935. Clin Cancer Res. 2006. PMID: 17020994 Free article.

6

VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth.

Yoo JY, Kim JH, Kwon YG, Kim EC, Kim NK, Choi HJ, Yun CO. Yoo JY, et al. Among authors: kim nk, kim jh, kim ec. Mol Ther. 2007 Feb;15(2):295-302. doi: 10.1038/sj.mt.6300023. Mol Ther. 2007. PMID: 17235307 Free article.

7

E1A- and E1B-Double mutant replicating adenovirus elicits enhanced oncolytic and antitumor effects.

Kim J, Kim JH, Choi KJ, Kim PH, Yun CO. Kim J, et al. Among authors: kim ph, kim jh. Hum Gene Ther. 2007 Sep;18(9):773-86. doi: 10.1089/hum.2006.167. Hum Gene Ther. 2007. PMID: 17725410

8

Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus.

Kang YA, Shin HC, Yoo JY, Kim JH, Kim JS, Yun CO. Kang YA, et al. Among authors: kim js, kim jh. Mol Ther. 2008 Jun;16(6):1033-40. doi: 10.1038/mt.2008.63. Epub 2008 Apr 8. Mol Ther. 2008. PMID: 18398429 Free article.

9

Evaluation of E1B gene-attenuated replicating adenoviruses for cancer gene therapy.

Kim J, Cho JY, Kim JH, Jung KC, Yun CO. Kim J, et al. Among authors: kim jh. Cancer Gene Ther. 2002 Sep;9(9):725-36. doi: 10.1038/sj.cgt.7700494. Cancer Gene Ther. 2002. PMID: 12189522

10

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner.

Kim E, Kim JH, Shin HY, Lee H, Yang JM, Kim J, Sohn JH, Kim H, Yun CO. Kim E, et al. Among authors: kim h, kim j, kim jh. Hum Gene Ther. 2003 Oct 10;14(15):1415-28. doi: 10.1089/104303403769211637. Hum Gene Ther. 2003. PMID: 14577922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,400 results

Search Page

Filters